NEWEST VIDEOS
Dr. Carlos Guerrero presents a comprehensive overview of subperception spinal cord stimulation (SCS), including FAST and Contour stimulation algorithms, at the Latin American Pain Society (LAPS) Congress. He explains the evolution of SCS from traditional paresthesia-based models to high-frequency and burst therapies that avoid paresthesia, offering faster and more personalized pain relief. Clinical studies show effectiveness in conditions like diabetic neuropathy, with improvements in quality of life, nerve size, and analgesic consumption. Dr. Guerrero emphasizes the need to democratize access to advanced neuromodulation technologies across Latin America and encourages collaboration to bridge gaps in care.
Watch Now
Watch Video
Personalized Therapy in SCS
NEWEST VIDEO
Activation Principles of Platelet Rich Plasma
Dr. Singh has been attending the NYNJ Pain Congress for over a decade and presented a compelling talk on platelet-rich plasma (PRP) activation and its role in regenerative medicine. Initially skeptical, his research at Weill Cornell Medicine revealed consistent functional and pain improvements in patients—even when imaging didn’t change—prompting deeper investigation into PRP dosing, growth factor release, and activation methods (calcium chloride, thrombin, freeze/thaw). He emphasized the importance of measuring platelet counts, tailoring therapy by indication, and advancing the field through standardized reporting (PLRA). His call to action: collaborate, count, and focus on patient outcomes—not just imaging.
Watch Now
Watch Now
Watch Now
NEWEST VIDEO
Watch Now
New Concept Osteogenic Pain
This talk explores osteogenic pain—pain originating from bone tissue—and credits Dr. Plancarte for introducing the concept. Dr. Jimenez Andrade traces the historical view of bone as merely structural, highlighting new evidence showing that bone is richly innervated, particularly with peptidergic sensory fibers, unlike skin, which has both peptidergic and non-peptidergic fibers. Using animal models of fracture and cancer, the team demonstrates that blocking the NGF/TRK pathway leads to analgesic effects. Human studies confirm similar nerve remodeling in bone metastases. The findings support a paradigm shift: bone is a distinct pain source with unique nerve characteristics, offering new therapeutic targets.
Minimally Invasive Procedures for Central and Neuroforaminal Spinal Stenosis
Dr. Steve Aydin reflects on the evolution of minimally invasive treatments for lumbar spinal stenosis, questioning whether these procedures truly change patient outcomes or mainly improve symptoms. He compares options like MILD (percutaneous lumbar decompression) and interspinous devices (Vertiflex, Minuteman), noting that while imaging rarely shows significant post-procedure change, patients often experience relief. The talk highlights challenges in patient selection, balancing risks like facet pain after spacers, and the importance of individualized algorithms for central versus foraminal stenosis. Aiden emphasizes adaptability as techniques evolve, aiming for the least invasive intervention with meaningful symptom improvement over aggressive surgical alternatives.
Watch Now
NEWEST VIDEO
Watch Now
NEWEST VIDEO
Intrathecal Neurolysis
This powerful presentation explores the role of intrathecal neurolysis in managing refractory cancer pain in palliative care. Highlighting that 30% of cancer patients do not respond to standard multimodal analgesia, Dr. Perez Moreno advocates for chemical neurolysis—primarily using alcohol or phenol—to achieve meaningful relief. Detailed comparisons between aqueous and glycerinated phenol and alcohol reveal their chemical behaviors, densities, and risk profiles. Through compelling clinical cases, including terminal patients requesting euthanasia due to unbearable pain, Dr. Perez Moreno demonstrates how carefully executed intrathecal neurolysis can offer dramatic pain relief, preserve dignity, and avoid motor complications, reinforcing its value as a compassionate, evidence-informed intervention.
Watch Now
Watch Now
Watch Now
Personalized Therapy in SCS
Dr. Carlos Guerrero presents a comprehensive overview of subperception spinal cord stimulation (SCS), including FAST and Contour stimulation algorithms, at the Latin American Pain Society (LAPS) Congress. He explains the evolution of SCS from traditional paresthesia-based models to high-frequency and burst therapies that avoid paresthesia, offering faster and more personalized pain relief. Clinical studies show effectiveness in conditions like diabetic neuropathy, with improvements in quality of life, nerve size, and analgesic consumption. Dr. Guerrero emphasizes the need to democratize access to advanced neuromodulation technologies across Latin America and encourages collaboration to bridge gaps in care. Watch Now
Dr. Singh has been attending the NYNJ Pain Congress for over a decade and presented a compelling talk on platelet-rich plasma (PRP) activation and its role in regenerative medicine. Initially skeptical, his research at Weill Cornell Medicine revealed consistent functional and pain improvements in patients—even when imaging didn’t change—prompting deeper investigation into PRP dosing, growth factor release, and activation methods (calcium chloride, thrombin, freeze/thaw). He emphasized the importance of measuring platelet counts, tailoring therapy by indication, and advancing the field through standardized reporting (PLRA). His call to action: collaborate, count, and focus on patient outcomes—not just imaging.
Activation Principles of Platelet Rich Plasma
Watch Now
This talk explores osteogenic pain—pain originating from bone tissue—and credits Dr. Plancarte for introducing the concept. Dr. Jimenez Andrade traces the historical view of bone as merely structural, highlighting new evidence showing that bone is richly innervated, particularly with peptidergic sensory fibers, unlike skin, which has both peptidergic and non-peptidergic fibers. Using animal models of fracture and cancer, the team demonstrates that blocking the NGF/TRK pathway leads to analgesic effects. Human studies confirm similar nerve remodeling in bone metastases. The findings support a paradigm shift: bone is a distinct pain source with unique nerve characteristics, offering new therapeutic targets.
New Concept Osteogenic Pain
Watch Now
Dr. Steve Aydin reflects on the evolution of minimally invasive treatments for lumbar spinal stenosis, questioning whether these procedures truly change patient outcomes or mainly improve symptoms. He compares options like MILD (percutaneous lumbar decompression) and interspinous devices (Vertiflex, Minuteman), noting that while imaging rarely shows significant post-procedure change, patients often experience relief. The talk highlights challenges in patient selection, balancing risks like facet pain after spacers, and the importance of individualized algorithms for central versus foraminal stenosis. Aiden emphasizes adaptability as techniques evolve, aiming for the least invasive intervention with meaningful symptom improvement over aggressive surgical alternatives.
Minimally Invasive Procedures for Central and Neuroforaminal Spinal Stenosis
Watch Now
This powerful presentation explores the role of intrathecal neurolysis in managing refractory cancer pain in palliative care. Highlighting that 30% of cancer patients do not respond to standard multimodal analgesia, Dr. Perez Moreno advocates for chemical neurolysis—primarily using alcohol or phenol—to achieve meaningful relief. Detailed comparisons between aqueous and glycerinated phenol and alcohol reveal their chemical behaviors, densities, and risk profiles. Through compelling clinical cases, including terminal patients requesting euthanasia due to unbearable pain, Dr. Perez Moreno demonstrates how carefully executed intrathecal neurolysis can offer dramatic pain relief, preserve dignity, and avoid motor complications, reinforcing its value as a compassionate, evidence-informed intervention.
Intrathecal Neurolysis
Published on July 25, 2019
Dr. Jan Van Zundert discusses recent events that have caused the loss of insurance coverage for radiofrequency ablation for facet pain. He explains how JAMA’s Mint RCT findings has caused...
